Dr Thomas Buttgereit is joined by Dr Carolina Vera to discuss the use of attenuated androgens in the treatment of hereditary angioedema and their associated risks and side effects. Both exerts delve into the safety, ethical considerations and alternative treatment options to using androgens for the treatment of hereditary angioedema. Dr Vera concludes the discussion with an in-depth explanation of the SHAERPA project, focusing on the discontinuation of androgen use in individuals with angioedema, and the benefits this project can have in providing guidance on alternative medications.
Listen on SPOTIFY and APPLE PODCASTS
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
For more information about the GA2LEN ACARE network and its activities please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update, Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series and and WAO Guideline for the Management of Hereditary Angioedema.
Read more news from ACARE
- July 28, 2023
A very warm welcome to Clínica Universidad de Navarra, who has joined the ACARE network on July 13, 2023. Head: Marta Ferrer Auditor: Ana M Giménez-Arnau This makes it our [...]
- November 8, 2023
Join Dr Andrea Zanichelli and Dr Thomas Buttgereit as they discuss complex angioedema cases, including acquired angioedema diagnosed in later life. Drawing from his perspective as Head of the Angioedema [...]
- January 26, 2023
The HAE Relay: Expert Exchange video series is designed to provide engaging and informative bite-size content to healthcare professionals who are either new to hereditary angioedema (HAE), or are established [...]
